Ledger.Open graph →
SEC Form D · Amendment · filed March 4, 2020

Serina Therapeutics, Inc

Offering
$76.2M
Sold
$3.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HUNTSVILLE, AL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

George P. Clancy · Washington, Washington, D.C.ExecMichael D. Bentley · Huntsville, ALExec · DirectorJason Carss · New York, NYExec · DirectorRandall W. Moreadith · Huntsville, ALExec · DirectorTacey R. Viegas · Madison, ALExecVincent L. Ammann · Washington, Washington, D.C.Exec · DirectorNancy C. Floyd · Washington, Washington, D.C.DirectorMiguel A. Loya · Houston, TXDirectorJ M. Harris · Huntsville, ALExec · DirectorRoberta W. Sims · Washington, Washington, D.C.DirectorJames R. Hudson, Jr · Huntsville, ALDirectorBarbara M. Fisk · Madison, ALDirectorJ M. Harris · Huntsville, ALExec · DirectorJeffrey Fried · Elmhurst, NYDirectorAlan Rutledge · San Francisco, CAExec · DirectorPatrick J. Haynes, Iii · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗